Commit
NDC Package 0135-0446-01

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Other Packages
    3. Frequently Asked Questions

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was discontinued by the firm.

Commit is a . Marketed by Glaxosmithkline Consumer Healthcare Lp, this product is identified by NDC 0135-0446 and is authorized under FDA application NDA021330.

Identification & Billing

NDC Package Code
0135-0446-01
Package Description
48 LOZENGE in 1 CONTAINER
Product Code
0135-0446
11-Digit Billing Format
00135044601

Clinical Specifications

Proprietary Name
Commit
Dosage Form
-

Regulatory & Marketing

Labeler Name
Glaxosmithkline Consumer Healthcare Lp
FDA Application #
NDA021330
Marketing Category
NDA - A product marketed under an approved New Drug Application.
Start Marketing Date
02-13-2004
End Marketing Date
02-28-2012
Listing Expiration
02-28-2012
Exclude Flag
D
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Other Available Packages

The following commercial packages are registered under the same Product NDC (0135-0446). Click a package code to view its specific billing and regulatory data.

0135-0446-02
72 LOZENGE in 1 CONTAINER
0135-0446-03
168 LOZENGE in 1 CONTAINER
0135-0446-07
144 LOZENGE in 1 CONTAINER

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 0135-0446-01 identifies a specific commercial package of 48 lozenge in 1 container of Commit, labeled by Glaxosmithkline Consumer Healthcare Lp. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Glaxosmithkline Consumer Healthcare Lp on February 13, 2004. The current certification is valid through February 28, 2012.

How is this Glaxosmithkline Consumer Healthcare Lp product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 00135044601. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (4-4-2)
0135-0446-01
11-Digit CMS (5-4-2)
00135-0446-01

Note: The zero is added to the Labeler segment to maintain the 5-4-2 structure.